|
|||||
|
|
||||||
Originally published as JCO Early Release 10.1200/JCO.2005.16.493 on September 12 2005 © 2005 American Society of Clinical Oncology. Defining Cancer Patients As Being in the Terminal Phase: Who Receives a Formal Diagnosis, and What Are the Effects?From the Research Units of General Practice, Health Economics, and Epidemiology, Institute of Public Health, University of Southern Denmark, Odense, Denmark Address reprint requests to B. Aabom, MD, Research Unit of General Practice, J.B. Winsloevs Vej 9A, DK-5000 Odense C, Denmark; e-mail: baabom{at}health.sdu.dk PURPOSE: Physicians either do not define cancer patients as being terminal, or their prognostic estimates tend to be optimistic. This might affect patients' appropriate and timely referral to specialist palliative care services or can lead to unintended acute hospitalization. PATIENTS AND METHODS: We used the Danish Cancer Register and four administrative registers to perform a retrospective cohort study in 3,445 patients who died as a result of cancer. We used the Danish "terminal declaration" issued by a physician as a proxy for a formal terminal diagnosis (prognosis of death within 6 months). The terminal declaration gives right to economic benefits and increased care for the dying. We investigated patient-related factors of receiving an explicit terminal diagnosis by logistic regression and then analyzed the effects of such a diagnosis on admission rate per week and place of death.
RESULTS: Thirty-four percent of patients received a formal terminal diagnosis. Age of CONCLUSION: Women and the elderly were less likely to receive a formal terminal diagnosis. The formal terminal diagnosis reduced hospital admissions and increased the possibilities of dying at home. Supported by the Health Insurance Foundation (Grants No. 2001B116 and 2002B025), the Danish Research Foundation for General Practice (Grant No. 586-193259), and the Danish College of General Practitioners' Foundation for Research in General Practice 2001. Authors' disclosures of potential conflicts of interest are found at the end of this article.
Related Editorial
This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|